FUJIFILM Holdings Corporation
FUJIYJPFUJIFILM Holdings Corporation, trading as FUJIY, is a global conglomerate that designs, produces, markets, and supports a wide range of solutions across imaging, healthcare, advanced materials, and business innovation sectors. The company was founded in 1934 and maintains its headquarters in Tokyo, Japan. Its Healthcare division provides an extensive suite of products and services geared towards prevention, diagnosis, and treatment. These offerings include state-of-the-art medical devices, specialized biomedical contract development and manufacturing organization (CDMO) services, pharmaceuticals, regenerative medicines, and various cosmetics and nutritional supplements. The Materials segment delivers crucial components and systems for industrial applications. This includes digital inkjet presses, printing plates, and related industrial inkjet products like inkjet heads for the printing industry. It also offers robust storage media and comprehensive archiving services for the management of large digital data volumes. Furthermore, this segment supplies a variety of industrial-grade materials for critical technologies such as displays, touch panels, semiconductors, image sensors, and functional films. FUJIFILM's Business Innovation segment is dedicated to enhancing workplace productivity and communication. It provides a portfolio of office equipment and services, encompassing digital multifunction devices, printers, software solutions, and cloud-based services. This division also develops workflow solutions for the graphical communications industry, including printing companies, and offers customized document services, from system integration to business process outsourcing, tailored to diverse organizational needs. Finally, the Imaging segment caters to both consumer and professional photographic and optical markets. For consumers, it offers traditional color films, instant cameras, photo processing systems, photographic papers, and photo printing services. For professional and industrial use, it manufactures high-performance television and cinema lenses, surveillance cameras, industrial lenses for production line inspections, and projectors.
Enterprise value over trailing (LTM) vs. forward (NTM) fundamentals. Click an LTM cell to chart it.
- Sector
- Medical Devices & Diagnostics
- Sub-sector
- Diagnostics & Imaging
- Listing
- FUJIY
- Country
- JP
EV / LTM Revenue
Annual financials & analyst forecasts
| $M | CY2021 | CY2022 | CY2023 | CY2024 | CY2025 | CY2026E | CY2027E |
|---|---|---|---|---|---|---|---|
| Revenue YoY | — | 11% | 6% | 7% | 6% | 5% | 5% |
| Revenue | $2.48T | $2.76T | $2.92T | $3.13T | $3.33T | $3.49T | $3.66T |
| Gross Profit | $1.00T | $1.09T | $1.17T | $1.27T | $1.35T | — | — |
| Gross Profit Margin | 40.5% | 39.5% | 40.1% | 40.4% | 40.5% | — | — |
| EBITDA | $400.80B | $403.19B | $461.24B | $471.06B | $548.88B | $547.72B | $574.01B |
| EBITDA Margin | 16.2% | 14.6% | 15.8% | 15.0% | 16.5% | 15.7% | 15.7% |
| EBIT | $231.46B | $245.89B | $275.37B | $295.08B | $358.40B | $369.10B | $386.81B |
| Net Income | $211.82B | $207.81B | $239.45B | $251.29B | $275.14B | $283.58B | $316.23B |
| Free Cash Flow | $186.80B | ($98.91B) | ($39.55B) | ($63.15B) | ($135.74B) | — | — |
| FCF Margin | 7.5% | -3.6% | -1.4% | -2.0% | -4.1% | — | — |
| Short-Term Debt | $154.70B | $220.93B | $373.60B | $275.52B | $335.57B | — | — |
| Long-Term Debt | $346.15B | $306.06B | $235.71B | $469.97B | $739.15B | — | — |
| Cash & Cash Equivalents | $425.05B | $317.84B | $242.94B | $216.25B | $188.26B | — | — |
| Net Debt | $75.80B | $209.14B | $366.36B | $529.24B | $886.45B | — | — |
| Net Debt / EBITDA | 0.2x | 0.5x | 0.8x | 1.1x | 1.6x | — | — |
| Rule of 40 | — | 7.7% | 4.5% | 5.3% | 2.1% | — | — |